Brixton Biosciences

We’re excited to share that Brixton Biosciences has been nominated for the ?? Emerging MedTech Company of the Year ?? award at the 12th Annual #NEVYs24! Thank you to the New England Venture Capital Association (NEVCA) for recognizing us! We can’t wait to join our fellow innovators in Tech, Tough Tech, Healthcare IT, Life Science, and MedTech and celebrate at the House of Blues on December 5th! #NEVYsSurvivor #NEVCA #Innovation #BrixtonBiosciences

?? Big news for Brixton! We’ve secured a $2M NIH HEAL Initiative grant to push the boundaries of drug-free pain relief. This funding accelerates our mission to develop long-lasting, non-addictive nerve block therapies that close the gap between temporary solutions and invasive treatments. Thank you to the The National Institutes of Health and the Helping to End Addiction Long-term??Initiative (HEAL) Initiative for believing in our vision—and to our incredible team, collaborators, and advisors for making this possible. #BrixtonBiosciences #NIHHEALInitiative #PainRelief #HealthcareInnovation #OpioidFree https://lnkd.in/ek8MWkn5

We are hiring a Clinical Support Specialist for our Clinical team! ?? Learn more here: https://lnkd.in/eiHW_T5e

?? News Alert! ?? Thrilled to announce a significant milestone for Brixton Biosciences as we close a Series B funding round of $33M! ?? This funding, led by Schooner Capital and supported by esteemed investors like SV Health Investors, Sparta Group LLC, Excelestar Ventures LLC, PV Capital Management, and CHV, propels us closer to our mission of revolutionizing pain management. At Brixton, we're committed to pioneering solutions that address crucial unmet needs in pain management. Our goal is to offer safe, effective, and non-addictive alternatives to traditional techniques & medications, providing patients with enduring relief and hope for a better quality of life. Thank you to our investors, partners, and supporters who believe in our vision. Together, we're poised to make a meaningful impact in the lives of millions suffering from pain. Stay tuned for more updates as we continue to push the boundaries of innovation! ?? #BrixtonBiosciences #NeuralIce #PainManagement #Innovation #SeriesBFunding #HealthcareRevolution Sameer Sabir, Michael A. Fishman, MD, MBA, Joanna Xylas, PhD, David Curd, Charles Sidoti, Anida Sahinovic, Zeinab Kheireddine, Olivier Kagan, Thomas Lad Merrill, Luca Del Vescovo, Aaron McPherson, Danielle Brucato, Natalie Scanlon https://lnkd.in/eR2-8tNe